Table 1.

Demographic and clinical summary of a patient group.

	TLE (N = 13)	FLE (N = 9)	HC (N = 100)
Gender	7x F, 6x M	7x F, 2x M	48x F, 52x  M
Age [± std]	34.86 y [± 9.48]	27.86 y [± 6.85]	31.65 y [± 8.35]
Avg no of seizures per month [± std]	5.67 y [± 4.97]	22.10 y [± 45.43]	–
Laterality	10x right 3x left	6x  right 3x left	–
Disease duration [± std]	24.24 y [± 10.52]	14.52 y [± 6.70]	–
Onset age [± std]	10.62 y [± 9.50]	13.33 y [± 7.48]	–
Histology	3x negativea 6x HS 1x FCD IIA 1x FCD IIB 1x FCD IIA + HS 1x MA	6x FCD IIA 1x FCD IIB 1x FCD (unspecified) 1x gliosis	–
ILAE (12 months)	9x ILAE 1 1x ILAE 3 3x ILAE 4	3x ILAE 1 1x ILAE 2 2x ILAE 3 3x ILAE 4	–

M, male; F, female; TLE, temporal lobe epilepsy; FLE, frontal lobe epilepsy; HC, healthy control; FCD, focal cortical dysplasia; HS, hippocampal sclerosis; y, years; MA, meningioangiomatosis.

^aPatients with negative histological findings were included only if they achieved ILAE outcome ≤ 4.